Jacobs Designs Award-Winning Facility for Pfizer
December 16 2014 - 7:45AM
Business Wire
Project Selected Overall Winner of 2014
Facility of the Year Awards
Jacobs Engineering Group Inc. (NYSE:JEC) announced today that a
project it executed on behalf of Pfizer Ireland Pharmaceuticals
received the 2014 Facility of the Year Award (FOYA) from the
International Society for Pharmaceutical Engineering (ISPE), the
sponsor of the awards program.
Pfizer Ireland’s Network Strategy Implementation Expansion
Capacity project re-purposed existing manufacturing space to add
capacity for new vaccine and multi-product, small-to-medium scale
drug substance bioprocess suites at Pfizer’s Grange Castle plant in
Clondalkin, South County Dublin.
Jacobs provided design services for the project, utilizing a
lean management strategy program during the design process to
ensure flow and operations. FOYA judges were impressed with the
project team’s ability to effectively maintain supply while
demolition, construction, start-up and integration activities
progressed.
In making the announcement, Jacobs Group Vice President Chris
Nagel stated, “It’s a pleasure to celebrate the success of this
award-winning project with Pfizer. We value our long-standing
relationship and appreciate the trust they continue to place in us
to support their business needs.”
The FOYA program recognizes pharmaceutical manufacturing
projects that use new and innovative technologies to enhance
project delivery and reduce production costs of high quality
medicines for patients worldwide. Jacobs has designed projects that
were selected as the overall FOYA winner for the past three
years.
Jacobs, one of the world's largest and most diverse providers of
technical professional and construction services, consistently
delivers award-winning pharmaceutical and biotechnology projects
worldwide.
Statements made in this release that are not based on historical
fact are forward-looking statements. We base these forward-looking
statements on management’s current estimates and expectations as
well as currently available competitive, financial and economic
data. Forward-looking statements, however, are inherently
uncertain. There are a variety of factors that could cause business
results to differ materially from our forward-looking
statements. For a description of some of the factors which may
occur that could cause actual results to differ from our
forward-looking statements please refer to our 2014 Form 10-K, and
in particular the discussions contained under Items 1 - Business,
1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management's
Discussion and Analysis of Financial Condition and Results of
Operations. We do not undertake to update any forward-looking
statements made herein.
Jacobs Engineering Group Inc.Michelle Jones, 626-578-6968
Jacobs Engineering (NYSE:JEC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Jacobs Engineering (NYSE:JEC)
Historical Stock Chart
From Jul 2023 to Jul 2024